- The point of care infectious disease market is witnessing steady growth as more consumers and healthcare providers prioritize rapid and accurate diagnostic solutions for efficient disease management
- Growing demand from both developed and developing regions is encouraging manufacturers to innovate with high-performance, portable, and user-friendly diagnostic solutions
- North America dominates the point of care infectious disease market with the largest revenue share of 51.5% in 2024, driven by a rising number of infectious diseases and advancements in technology, coupled with advanced healthcare infrastructure
- Asia-Pacific is expected to be the fastest growing region in the point of care infectious disease market during the forecast period, driven by a rapid increase in the geriatric population, rising cases of infectious diseases, and substantial investments in healthcare infrastructure enhancement, particularly in countries such as China, India, and Southeast Asian nations
- The molecular diagnostic segment holds the largest market share of 43.5% in 2024, driven by its superior sensitivity and capability to identify multiple pathogens simultaneously. Its precision and rapid results enhance disease detection, supporting efficient clinical decision-making and advancing diagnostic technologies globally
